
|

| |
Track the *RXDIA Index |
 |
|
 | Diabetes Stocks (*RXDIA) |
| |
Diabetes Ideas |
|
|
|
Diabetes Performance |
|
|
|
Diabetes Community |
|
| |
|
Index Description: These medical firms have significant exposure to treatments and therapies for diabetes
|
|
|
|
|
Today:
1-month:
All-time:
|
-0.7%
+11.8%
+1.7%
|
vs S&P 500:
vs S&P 500:
vs S&P 500:
|
+0.3%
+5.9%
-18.0%
|
Avg. Market Cap:
Avg. P/E Ratio:
Avg. Div Yield:
|
$10.9B
0.0
0.1%
|
|
|
|
|
Share this Index on Facebook
Share this Index on Twitter
|
|
| |
|
|
|
|
|
|
|
|
|
|
| |
|
| |

Click
a column to sort | Scroll over columns for more information |
|
|
| ARRY |
$5.80 |
-0.08 |
-1.3% |
987,219 |
70% |
$686.1M |
- |
93% |
-12% |
No Alerts/News
|
|
|
| BIOD |
$3.63 |
+0.20 |
+6.0% |
249,307 |
307% |
$48.7M |
- |
71% |
-5% |
No Alerts/News
|
|
|
| DEPO |
$5.72 |
-0.02 |
-0.3% |
421,168 |
73% |
$324.3M |
- |
20% |
-20% |
No Alerts/News
|
|
|
| DXCM |
$20.34 |
-0.79 |
-3.7% |
689,823 |
107% |
$1.4B |
- |
98% |
-6% |
1 Alert (0 News) - View
|
|
|
| GNBT |
$0.03 |
0.00 |
+15.4% |
6,766,877 |
567% |
$19.4M |
- |
54% |
-73% |
No Alerts/News
|
|
|
| MNKD |
$6.15 |
+0.79 |
+14.7% |
21,953,371 |
361% |
$1.5B |
- |
289% |
13% |
2 Alerts (0 News) - View
|
|
|
| NVO |
$169.26 |
-1.88 |
-1.1% |
291,855 |
113% |
$93.2B |
1.3% |
31% |
-13% |
No Alerts/News
|
|
|
| PODD |
$28.59 |
-1.15 |
-3.9% |
221,269 |
41% |
$1.5B |
- |
65% |
-5% |
1 Alert (0 News) - View
|
|
|
| SPEX |
$7.15 |
0.00 |
0.0% |
100 |
3% |
$5.8M |
- |
30% |
-56% |
No Alerts/News
|
|
|
|
Is this index incomplete or incorrect?
Got an idea for a new Index?
|
|
|
| |

|
| |
|
| |

|
| |
'Love Hormone' Promises Safer Births After Pfizer Flop PFE MNKD NKTR
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 19, 06:03PM from (www.bloomberg.com) A hormone treatment based on technology used in Pfizer Inc. (PFE)’s failed inhalable insulin shows promise in fighting the leading cause of maternal mortality.
Flag
Post a comment
AstraZeneca Advances Three Cancer Drugs Into Late-Stage Trials ARRY
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 16, 02:18AM from (www.bloomberg.com) AstraZeneca Plc (AZN) will move three experimental cancer treatments into late-stage development as generic competition for its best-selling drugs intensifies.
Flag
Post a comment
MannKind Corporation Reports 2013 First Quarter Financial Results MNKD
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 09, 04:00PM from (www.businesswire.com) MannKind Corporation (Nasdaq: MNKD) today reported financial results for the first quarter ended March 31, 2013. For the
Flag
Post a comment
Biodel Reports Second Quarter Fiscal Year 2013 Financial Results BIOD
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 08, 07:43AM from (globenewswire.com) DANBURY, Conn., May 8, 2013 (GLOBE NEWSWIRE) -- Biodel Inc. (Nasdaq:BIOD) today reported financial results for the second
Flag
Post a comment
Insulet Corporation to Report First Quarter 2013 Financial Results on May 6, 2013 PODD
Linked by marketwire ( track newsfeed | ignore newsfeed ) - April 23, 04:48PM from (www2.marketwire.com) Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management
Flag
Post a comment
Merck’s $4 Billion Diabetes Drug in Trouble? BMY LLY MRK NVO AZN
Linked by YCHARTS ( track newsfeed | ignore newsfeed ) - April 18, 11:55AM from (ycharts.com) For the past two months, there has been rising controversy over the extent to which certain diabetes drugs called GLP-1 inhibitors
Flag
Post a comment
Mid-Day Market Update: Precious Metals Take a Beating as Markets Recover JPM WFC RAD MNKD SBGI NG AUY ASH
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - April 12, 01:34PM from (www.benzinga.com) Midway through trading Friday, the Dow traded down 0.04 percent to 14,858.98 while the NASDAQ fell 0.34 percent to 3,289.44.
Flag
Post a comment
Mid-Day Market Update: ADTRAN Soars as Titan Takes a Hit HMA MNKD JDSU ADTN FSLR TITN
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - April 10, 12:53PM from (www.benzinga.com) Midway through trading Wednesday, the Dow traded up 0.97 percent to 14,815.98 while the NASDAQ rose 1.79 percent to 3,295.44.
Flag
Post a comment
Market Close: Big Winners & Losers for April 2, 2013 SPEX TCCO CLNT NAT BOSC IGOI BGCP NDAQ OPTR CHCI
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - April 02, 04:27PM from (247wallst.com) Here are today’s five biggest gaining stocks at closing: BGC Partners Inc. (NASDAQ: BGCP) is up 48.3% at $5.71. B.O.S.
Flag
Post a comment
|
|
|